Search

You searched for "outcomes"

1677 results found

Oertli Instrumente AG achieves milestone with FDA 510(k) clearance for Faros surgical system

24 July 2024 | Research & Development
Oertli Instrumente AG, a leader in innovative surgical solutions for ophthalmology, is proud to announce the U.S. Food and Drug Administration (FDA) 510(k) clearance for the worldwide established Faros anterior cataract surgery system. This milestone underscores Oertli's global reach and...

Haag-Streit Academy announces course schedule for 2025

21 November 2024 | Company Profiles, Research & Development
Haag-Streit Academy are pleased to announce their course schedule for 2025, which features eight slit lamp and biometry courses in prime locations across the UK. The courses offer attendees the vital skills and knowledge to utilise their slit lamp and...

RayOne EMV honoured with King’s Award for Enterprise

8 May 2025 | Awards, Conferences & Anniversaries
Rayner, the UK’s sole manufacturer of intraocular lenses (IOLs) and a global leader in cataract surgery solutions, has received the prestigious King’s Award for Enterprise 2025 in the Innovation category for its groundbreaking RayOne EMV lens. Launched in 2020 and...
Clinical & Experimental Ophthalmology journal cover image.

Changes in the prevalence of myopia in middle-aged caucasian Australians compared to UK biobank

5 August 2022 | | EYE - Vitreo-Retinal
This article compares rates of myopia and high myopia in large cohorts of caucasian Australians from the Busselton Healthy Ageing Study, the urban Gen1 of the Raine Study, the Blue Mountains Eye study and Melbourne Visual Impairment Project. The former...
Journal of Pediatric Ophthalmology & Strabismus cover image.

Increase in myopia during the Covid-19 lockdown periods

3 June 2024 | | EYE - Paediatrics, EYE - Strabismus
The aim of this study was to examine the effect of the Covid-19-related lockdown on myopia progression of school-aged children in Lebanon. The authors reviewed 443 records of myopic children aged 3–18 years (mean 11.81 ±3.67) presenting from January 2020...

Technique of deep corneal foreign body removal

3 February 2026 | | EYE - Glaucoma, EYE - Cornea
This article has been verified for CPD. Click the button below to answer a few short questions and download a form to be included in your CPD folder. The objective is to demonstrate a method for the safe and successful...

HS-UK to be authorised distributor for the Vision Engineering 3D Deep Reality Viewer

23 January 2023 | Contracts & Distributors
HS-UK is delighted to announce that it is now the authorised distributor for the Deep Reality Viewer (DRV) in the UK.

Sharing best practice and landmark evidence in glaucoma care

1 August 2019 | | EYE - Glaucoma, EYE - General
Evolving technology, best practice and landmark evidence in glaucoma care were reviewed by an international expert faculty in session presentations and debates during the 11th Moorfields International Glaucoma Symposium 2019. The authors were meeting chairs and provide an overview of...

Acanthaemoeba keratitis

1 December 2017 | EYE - Cornea
In the second of this series I describe a case of Acanthaemoeba keratitis (AK) that was misdiagnosed for a prolonged period which resulted in a devastating outcome. This is one of half a dozen similar medico-legal cases I have dealt...

Considerations in the management of retinal disorders

1 October 2017 | | EYE - Vitreo-Retinal
Vision research presentations and publications explore practice considerations in the management of AMD and diabetic retinopathy. Over the past two decades in Europe there has been a decreasing prevalence of age-related macular degeneration (AMD) and an improvement in visual acuity...

Embracing assistive technology in the fight against sight loss

10 June 2020 | | EYE - General
The author shares his own experience of sight loss and explains the vital role assistive technology can play in the lives of visually impaired patients. There is no doubt that sight loss continues to be a clear and present danger,...

High-stakes scenarios in retinal vein occlusion: A survey of medico-legal implications

2 October 2025 | | EYE - Vitreo-Retinal, EYE - Glaucoma
Central retinal vein occlusion (CRVO) is the second most common retinal vascular disease after diabetic retinopathy, and its clinical complexity often intersects with medico-legal scrutiny [1]. Missteps in timely diagnosis, inadequate follow-up or poor documentation can lead to patient harm...